|Day Low/High||2.14 / 2.32|
|52 Wk Low/High||1.40 / 5.75|
Go on the offensive rather than turn defensive and miss the opportunities that are developing.
I'm keeping FIVE on the radar but will look for entry after it consolidates a bit.
Despite $5.1 billion deal for Costa, I'm not slurping any KO up.
I expect CRM to regain its footing quickly and challenge highs again soon.
Apple in particular is helping the bullish cause.
HTG Molecular Diagnostics and Amyris are poised for substantial growth.
With indexes within striking distance of their all-time highs in afternoon trading, it's time to take out a little insurance.
If there is any good news on trade the potential for more market upside is strong.
But in a narrow field, finding suppliers may be an issue.
The market is quietly holding up, and I'm not anticipating a major fade at this point.
This nearly unknown name combines cutting-edge technology with a promising business model.
This nearly unknown name combines cutting edge technology with a promising business model.